Safety and immunogenicity of recombinant Bacille Calmette-Guerin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine

By Edelman R.   Palmer K.   Russ K.G.   Secrest H.P.   Anna L. Becker J.   Bodison S.A.   Perry J.G.   Sills A.R.   Barbour A.G.   Luke C.J.   Hanson M.S.   Stover C.K.   Burlein J.E.   Bansal G.P.   Connor E.M.   Koenig S.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 904-914

Elsevier

Access to resources Recommend Favorite

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi

By Golde W.T.   Burkot T.R.   Piesman J.   Dolan M.C.   Capiau C.   Hauser P.   Dequesne G.   Lobet Y.  

Vaccine, Vol. 13, Iss. 5, 1995-01 ,pp. : 435-441

Elsevier

Access to resources Recommend Favorite

Inducing immunological response to Borrelia burgdorferi using outer membrane protein A; for use as a Lyme disease oral recombinant vaccine

By Barbour A.G.   Luke C.J.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 436-436

Elsevier

Access to resources Recommend Favorite

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey

By Philipp M.T.   Lobet Y.   Bohm R.P.   Roberts E.D.   Dennis V.A.   Gu Y.   Lowrie R.C.   Desmons P.   Duray P.H.   England J.D.   Hauser P.   Piesman J.   Xu K.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1872-1887

Elsevier

Access to resources Recommend Favorite

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults

By Van Hoecke C.   Comberbach M.   De Grave D.   Desmons P.   Fu D.   Hauser P.   Lebacq E.   Lobet Y.   Voet P.  

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1620-1626

Elsevier

Access to resources Recommend Favorite